论文部分内容阅读
目的分析缬沙坦治疗扩张型心肌病临床疗效。方法 2009年3月至2011年3月临床共收治扩张型心肌病患者48例,将患者分为治疗组和对照组。治疗组24例采取常规治疗加缬沙坦治疗,对照组24例采取常规治疗,治疗后观察2组临床疗效。结果两组治疗后心功能指标较治疗前均明显改善,观察组总有效率为87.5%,对照组总有效率为70.3%,两组总有效率比较,差异有统计学意义(P<0.05)。结论扩张型心肌病患者使用缬沙坦治疗,临床效果好,不良反应少,值得临床应用。
Objective To analyze the clinical efficacy of valsartan in the treatment of dilated cardiomyopathy. Methods From March 2009 to March 2011, 48 patients with dilated cardiomyopathy were enrolled, and the patients were divided into treatment group and control group. Twenty-four patients in the treatment group received conventional therapy plus valsartan, and 24 in the control group took conventional therapy. After treatment, the clinical efficacy was observed in both groups. Results After treatment, the indexes of cardiac function were significantly improved in both groups. The total effective rate was 87.5% in the observation group and 70.3% in the control group. There was significant difference between the two groups in the total effective rate (P <0.05) . Conclusion Dilated cardiomyopathy patients treated with valsartan, clinical effect, less adverse reactions, it is worth clinical application.